Sally Beer

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

Mark Ainsworth, Monique Andersson, Kathryn Auckland et al. · The Lancet Infectious Diseases · 2020 · 405 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

Ian Roberts, Haleema Shakur‐Still, Adefemi Afolabi et al. · The Lancet · 2020 · 389 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14